138
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Biomarkers of exposure to endogenous oxidative and aldehyde stress

, , , , &
Pages 453-456 | Received 11 Mar 2011, Accepted 08 Apr 2011, Published online: 22 Jul 2011

References

  • Ahmed N, Thornalley PJ, Dawczynski J, Franke S, Strobel J, Stein G, Haik GM. (2003). Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest Ophthalmol Vis Sci 44:5287–5292.
  • Benov L, Beema AF. (2003). Superoxide-dependence of the short chain sugars-induced mutagenesis. Free Radic Biol Med 34:429–433.
  • Berlett BS, Stadtman ER. (1997). Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316.
  • Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. (1997). Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23:361–366.
  • Chang D, Wang F, Zhao YS, Pan HZ. (2008). Evaluation of oxidative stress in colorectal cancer patients. Biomed Environ Sci 21:286–289.
  • Chaplen FW, Fahl WE, Cameron DC. (1998). Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc Natl Acad Sci USA 95:5533–5538.
  • Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. (2003). Protein carbonylation in human diseases. Trends Mol Med 9:169–176.
  • Eaton P, Wright N, Hearse DJ, Shattock MJ. (2002). Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. J Mol Cell Cardiol 34:1549–1560.
  • Esterbauer H, Zollner H. (1989). Methods for determination of aldehydic lipid peroxidation products. Free Radic Biol Med 7:197–203.
  • Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, Ochi H, Nonaka M, Nabeshima Y, Inoue M, Ishitobi T, Chayama K, Tazuma S. (2007). Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 22:1112–1119.
  • Il’yasova D, Mixon G, Wang F, Marcom PK, Marks J, Spasojevich I, Craft N, Arredondo F, DiGiulio R. (2009). Markers of oxidative status in a clinical model of oxidative assault: A pilot study in human blood following doxorubicin administration. Biomarkers 14:321–325.
  • Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. (2005). Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38:698–710.
  • Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Hanssen KF, Laakso M. (2009). Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women. Atherosclerosis 205:590–594.
  • Lee O, Bruce WR, Dong Q, Bruce J, Mehta R, O’Brien PJ. (2009). Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact 178:332–339.
  • Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC. (1995). Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem 228:294–298.
  • Mak S, Lehotay DC, Yazdanpanah M, Azevedo ER, Liu PP, Newton GE. (2000). Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure. J Card Fail 6:108–114.
  • McKeown-Eyssen G, Bruce J, Lee O, O’Brien PJ, Bruce WR. (2010). Lifestyle, endogenous toxins and colorectal cancer risk. In: O’Brien PJ, Bruce WR, eds. Endogenous Toxins. Weinheim, Germany: Wiley-VCH, pp. 617–694.
  • Mehta R, Wong L, O’Brien PJ. (2009). Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes. Chem Biol Interact 178:317–323.
  • Mitchel RE, Birnboim HC. (1977). The use of Girard-T reagent in a rapid and sensitive methods for measuring glyoxal and certain other alpha-dicarbonyl compounds. Anal Biochem 81:47–56.
  • Mohanty JG, Bhamidipaty S, Evans MK, Rifkind JM. (2010). A fluorimetric semi-microplate format assay of protein carbonyls in blood plasma. Anal Biochem 400:289–294.
  • Murata-Kamiya N, Kamiya H, Iwamoto N, Kasai H. (1995). Formation of a mutagen, glyoxal, from DNA treated with oxygen free radicals. Carcinogenesis 16:2251–2253.
  • Ni J, Yuan X, Gu J, Yue X, Gu X, Nagaraj RH, Crabb JW; Clinical Genomic and Proteomic AMD Study Group. (2009). Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration. Mol Cell Proteomics 8:1921–1933.
  • Nomi Y, Aizawa H, Kurata T, Shindo K, Nguyen CV. (2009). Glutathione reacts with glyoxal at the N-terminal. Biosci Biotechnol Biochem 73:2408–2411.
  • O’Brien PJ, Feng CY, Lee O, Rhea M, Bruce J, Bruce WR. (2010). Fructose-derived endogenous toxins. In: O’Brien PJ, Bruce WR, eds. Endogenous Toxins. Weinheim, Germany: Wiley-VCH, pp. 173–212.
  • O’connor T, Ireland LS, Harrison DJ, Hayes JD. (1999). Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J 343 Pt 2:487–504.
  • Phillips SA, Thornalley PJ. (1993). The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 212:101–105.
  • Reznick AZ, Packer L. (1994). Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Meth Enzymol 233:357–363.
  • Richard JP. (1991). Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction’s physiological significance. Biochemistry 30:4581–4585.
  • Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M. (1998). Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101:1142–1147.
  • Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T. (1999). Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol Med 5:393–405.
  • Takeuchi M, Yanase Y, Matsuura N, Yamagishi Si S, Kameda Y, Bucala R, Makita Z. (2001). Immunological detection of a novel advanced glycation end-product. Mol Med 7:783–791.
  • Tan AL, Forbes JM, Cooper ME. (2007). AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 27:130–143.
  • Tessier FJ, Monnier VM, Sayre LM, Kornfield JA. (2003). Triosidines: Novel Maillard reaction products and cross-links from the reaction of triose sugars with lysine and arginine residues. Biochem J 369:705–719.
  • Thornalley PJ, Langborg A, Minhas HS. (1999). Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344 Pt 1:109–116.
  • Thornalley PJ. (1993). The glyoxalase system in health and disease. Mol Aspects Med 14:287–371.
  • Usui T, Ohguchi M, Watanabe H, Hayase F. (2008). The formation of argpyrimidine in glyceraldehyde-related glycation. Biosci Biotechnol Biochem 72:568–571.
  • Vander Jagt D. (1989). The glyoxalase system. In: Dolphin D, Poulson R, Avramovic O, eds. Glutathione: Chemical, Biochemical and Medical Aspects. Part A. New York: John Wiley & Sons, pp. 597–641.
  • Vander Jagt DL. (2008). Methylglyoxal, diabetes mellitus and diabetic complications. Drug Metabol Drug Interact 23:93–124.
  • Vander Jagt DL, Hunsaker LA, Vander Jagt TJ, Gomez MS, Gonzales DM, Deck LM, Royer RE. (1997). Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol 53:1133–1140.
  • Vander Jagt DL, Kolb NS, Vander Jagt TJ, Chino J, Martinez FJ, Hunsaker LA, Royer RE. (1995). Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta 1249:117–126.
  • Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. (1992). Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 267:4364–4369.
  • Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. (2001). Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280:E685–E694.
  • World Cancer Research Fund/American Institute for Cancer Research. (2007). Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: AICR.
  • Yan SF, Ramasamy R, Naka Y, Schmidt AM. (2003). Glycation, inflammation, and RAGE: A scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159–1169.
  • Yeh CC, Lai CY, Hsieh LL, Tang R, Wu FY, Sung FC. (2010). Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer. Carcinogenesis 31:228–233.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.